| 9822169 |
Compositions and methods of use for determination of HE4a |
Karl E. Hellstrom, John RAYCRAFT, Christian FERMÉR, Eva RÖIJER |
2017-11-21 |
|
| 9090712 |
Diagnosis of carcinomas |
Jeffrey A. Ledbetter, Martha Hayden-Ledbetter |
2015-07-28 |
|
| 7745159 |
Methods and compositions for diagnosing carcinomas |
Nathalie Scholler, Karl E. Hellstrom |
2010-06-29 |
|
| 7547681 |
Surface receptor antigen vaccines |
Nathalie Scholler, Mary L. Disis, Karl E. Hellstrom |
2009-06-16 |
|
| 7270960 |
Diagnosis of ovarian carcinomas |
Jeffrey A. Ledbetter, Martha Hayden-Ledbetter |
2007-09-18 |
|
| 6770445 |
Methods and compositions for diagnosing carcinomas |
Nathalie Scholler, Karl E. Hellstrom |
2004-08-03 |
|
| 6734172 |
Surface receptor antigen vaccines |
Nathalie Scholler, Mary L. Disis, Karl E. Hellstrom |
2004-05-11 |
|
| 6183734 |
Inhibition of tumor cell growth by administration of B7-transfected cells |
Lieping Chen, Karl E. Hellstrom, Jeffrey A. Ledbetter, Peter S. Linsley |
2001-02-06 |
$240,181,000 |
| 6020145 |
Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96 |
Karl E. Hellstrom, Kim Folger Bruce, George J. Schreiber |
2000-02-01 |
$241,833,000 |
| 5980896 |
Antibodies reactive with human carcinomas |
Karl E. Hellstrom, Kim Folger Bruce, George J. Schreiber, Clay B. Siegall, Stephen McAndrew |
1999-11-09 |
$149,017,000 |
| 5840854 |
Monoclonal antibody BR110 and uses thereof |
Karl E. Hellstrom, Ursula Garrigues, Stephen McAndrew, Hans Marquardt |
1998-11-24 |
$173,280,000 |
| 5811098 |
Antibodies to HER4, human receptor tyrosine kinase |
Gregory D. Plowman, Jean-Michel Culouscou, Mohammed Shoyab, Clay B. Siegall, Karl E. Hellstrom |
1998-09-22 |
$166,236,000 |
| 5766588 |
Tumor immunotherapy using anti-idiotypic antibodies |
Karl E. Hellstrom, Victor K. Lee |
1998-06-16 |
$639,089,000 |
| 5614610 |
Tumor immunotherapy using anti-idiotypic antibodies |
Karl E. Hellstrom, Maria S. Kahn, Donna F. Beaton |
1997-03-25 |
$320,881,000 |
| 5597707 |
Tumor associated antigen recognized by the murine monoclonal antibody L6, its oligonucleotide sequence and methods for their use |
John Marken, Gary L. Schieven, Karl E. Hellstrom, Alejandro A. Aruffo |
1997-01-28 |
$141,605,000 |
| 5491088 |
Monoclonal antibody BR 96 and chimeric monoclonal antibodies having the variable region of MAB BR96, which bind to a variant of ley antigen on human carcimona cells |
Karl E. Hellstrom, Kim Folger Bruce, George J. Schreiber |
1996-02-13 |
|
| 5411884 |
Monoclonal antibody L53 which recognizes a human tumor-associated antigen |
Karl E. Hellstrom, Hans Marquardt, Janet V. Johnston |
1995-05-02 |
|
| 5262177 |
Recombinant viruses encoding the human melanoma-associated antigen |
Joseph P. Brown, Charles D. Estin, Gregory D. Plowman, Timothy M. Rose, Karl E. Hellstrom +3 more |
1993-11-16 |
$27,465,000 |
| 5242824 |
Monoclonal antibody to human carcinomas |
Karl E. Hellstrom |
1993-09-07 |
$152,034,000 |
| 5185432 |
Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas |
Karl E. Hellstrom, Joseph P. Brown, Hans Marquardt |
1993-02-09 |
$24,847,000 |
| 5171665 |
Monoclonal antibody to novel antigen associated with human tumors |
Karl E. Hellstrom, Hans Marquardt |
1992-12-15 |
$53,590,000 |
| 5165922 |
Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy |
Karl E. Hellstrom, Gary E. Goodman |
1992-11-24 |
$26,365,000 |
| 5141742 |
Vaccines against melanoma |
Joseph P. Brown, Charles D. Estin, Gregory D. Plowman, Timothy M. Rose, Karl E. Hellstrom +3 more |
1992-08-25 |
$40,068,000 |
| 5134075 |
Monoclonal antibody to novel antigen associated with human tumors |
Karl E. Hellstrom, Hans Marquardt, Yoshitaka Yoneyama |
1992-07-28 |
|
| 5091178 |
Tumor therapy with biologically active anti-tumor antibodies |
Karl E. Hellstrom |
1992-02-25 |
$29,410,000 |
